लोड हो रहा है...

Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters

INTRODUCTION: Benefits of disease-modifying anti-rheumatic drugs (DMARD) in early rheumatoid arthritis patients (ERAP) will be achieved if patients follow prescribed treatment. Objective was to investigate whether timing of first non-persistence period and/or duration of persistence during the first...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Arthritis Res Ther
मुख्य लेखकों: Contreras-Yáñez, Irazú, Pascual-Ramos, Virginia
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4499189/
https://ncbi.nlm.nih.gov/pubmed/26162892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-015-0697-z
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!